Detalhe da pesquisa
1.
Secukinumab as a potential trigger of inflammatory bowel disease in ankylosing spondylitis or psoriatic arthritis patients.
Rheumatology (Oxford)
; 60(11): 5233-5238, 2021 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33677579